Dianthus Therapeutics Inc.(DNTH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DNTH Dianthus Therapeutics Inc.

Market Closed 10-09 16:00:00 EDT

82.37

-0.06

-0.07%

盘后82.37

+0.000.00%

19:32 EDT

High85.20	Low82.13	Vol738.87K
Open82.36	D1 Closing82.43	Amplitude3.72%
Mkt Cap4.61B	Tradable Cap4.60B	Total Shares55.93M
T/O61.30M	T/O Rate1.32%	Tradable Shares55.85M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DNTH","market":"US","secType":"STK","nameCN":"Dianthus Therapeutics Inc.","latestPrice":82.37,"timestamp":1791576000000,"preClose":82.43,"halted":0,"volume":738872,"hourTrading":{"tag":"盘后","latestPrice":82.37,"preClose":82.37,"latestTime":"19:32 EDT","volume":152912,"amount":12595341.55,"timestamp":1791588733309,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0007278903311901282,"floatShares":55850100,"shares":55934399,"eps":-4.113023,"marketStatus":"Market Closed","change":-0.06,"latestTime":"10-09 16:00:00 EDT","open":82.36,"high":85.2,"low":82.13,"amount":61303940.151719995,"amplitude":0.037244,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.113023,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":82.43,"preHourTrading":{"tag":"盘前","latestPrice":85.3,"preClose":82.43,"latestTime":"09:28 EDT","volume":10,"amount":839.6800000000001,"timestamp":1791552480089,"change":2.87,"changeRate":0.034817,"amplitude":0.052165},"postHourTrading":{"tag":"盘后","latestPrice":82.37,"preClose":82.37,"latestTime":"19:32 EDT","volume":152912,"amount":12595341.55,"timestamp":1791588733309,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8666575332397486,"impliedVol":0.8115,"impliedVolPercentile":0.9562},"requestUrl":"/m/hq/s/DNTH/tweets","defaultTab":"tweets","newsList":[{"id":"2672762734","title":"Dianthus Therapeutics Grants New Hires Stock Options for 106,000 Shares at $88.32 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762734","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762734?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:00","pubTimestamp":1790888428,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics grants new hires stock options for 106,000 shares at $88.32 eachDianthus Therapeutics granted inducement equity awards on Oct. 1, 2026 to six newly hired non-executive employees.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL6JXktk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD","DNTH","SG9999014013.SGD","LU0314104364.USD","BK4112","IE00BN0W2V16.EUR","NDAQ","BK4588","SG9999014005.SGD","IE00BQXX3D17.EUR","IBRN","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","BK4139","IE00BQXX3F31.USD","IE00B64PRP62.GBP","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762787","title":"Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762787","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762787?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:00","pubTimestamp":1790888400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA955WXC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671521211","title":"Dianthus Therapeutics to Present Phase 3 Captivate Interim Analysis of Claseprubart in CIDP at 2026 AANEM Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2671521211","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671521211?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:01","pubTimestamp":1790683277,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics to present Phase 3 CAPTIVATE interim analysis of claseprubart in CIDP at 2026 AANEM meetingDianthus Therapeutics flagged new clinical updates for its complement inhibitor clasepr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL62W9hR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00BN0W2V16.EUR","BK4585","IE00BQXX3D17.EUR","BCDF","SG9999014039.USD","BK4588","SG9999014005.SGD","LU2210150020.SGD","DNTH","BK4112","BK4139","NDAQ","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973172","title":"Dianthus Therapeutics Chief Accounting Officer Edward Carr Disposes of Shares for $2.01 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973172","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973172?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:37","pubTimestamp":1789763825,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Chief Accounting Officer Edward Carr disposes of shares for $2.01 millionDianthus Therapeutics reported Chief Accounting Officer Edward Carr exercised stock options for 20,000 sh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL6j4XMn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus Therapeutics Chief Accounting Officer Edward Carr Disposes of Shares for $2.01 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","DNTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668536973","title":"Dianthus files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2668536973","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668536973?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:05","pubTimestamp":1789761909,"startTime":"0","endTime":"0","summary":"16:03 EDT Dianthus (DNTH) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668978775","title":"Dianthus Therapeutics Inc: Files for Mixed Shelf Offering; Size not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668978775","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668978775?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:03","pubTimestamp":1789761798,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nFWN45A0JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666541939","title":"U.S. Research Roundup- Adobe, Chewy, Mosaic","url":"https://stock-news.laohu8.com/highlight/detail?id=2666541939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666541939?lang=en_us&edition=fundamental","pubTime":"2026-09-11 15:09","pubTimestamp":1789110591,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Adobe, Chewy, MosaicSept 11 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Chewy and Mosaic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4N4530JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAYX","AIPI","DNTH","JBLU","ALGT","OLN","MEDI","EMN","SPLTRmain","SHW","ALK","CE","PLTR","PLTW","AAL","LUV","ATO","HUN","UAL","AXTA","AVAV","CF","ADBE","AEO","MOS","PLTI","IFF","ULCC","PBJ","PPG","CHWY","APD","AVXX","OMDA","ORCU","ORCL","RPM","MNPR","DAL","LH","LEGN","KROP","CTVA","ORCS","OVID","VVV","AALG","ONB","ELF","FMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666254398","title":"Dianthus Therapeutics Inc : JP Morgan Initiates Coverage with Overweight Rating; Price Target $135","url":"https://stock-news.laohu8.com/highlight/detail?id=2666254398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666254398?lang=en_us&edition=fundamental","pubTime":"2026-09-11 12:34","pubTimestamp":1789101255,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN4520M0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664335196","title":"Dianthus Therapeutics Inc : Citigroup Initiates Coverage with Buy Rating; Target Price $156","url":"https://stock-news.laohu8.com/highlight/detail?id=2664335196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664335196?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:09","pubTimestamp":1788516590,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44W0N3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664840383","title":"U.S. Research Roundup-Ciena Corp, Docusign, Snowflake","url":"https://stock-news.laohu8.com/highlight/detail?id=2664840383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664840383?lang=en_us&edition=fundamental","pubTime":"2026-09-04 15:08","pubTimestamp":1788505701,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Ciena Corp, Docusign, SnowflakeSept 4 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ciena...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4N44W0I0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RTH","VSXY","FCPT","NNN","IOT","PHM","PL","SNOW","DNTH","SRHR","LEN","AKAM","WPC","DOCU","CLYM","PATH","FERG","BP","ORA","CIEN","AQWA","PCG","INDS","MARS","DAT","CBNK","SNOY","IONS","COTG","ZS","AMBA","SAIA","TSN","ALGS","ASAN","OBT","PCAR","NETL","FSTA","SFNC","CURV","COST","FLNC","O","CTRI","HP","BLTE","CLIM","PTEN","GWRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664236801","title":"Dianthus EVP, Head of R&D Simrat Randhawa Sells USD 2.45 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664236801","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664236801?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:31","pubTimestamp":1788467497,"startTime":"0","endTime":"0","summary":"Dianthus EVP, Head of R&D Simrat Randhawa sells USD 2.45 million in common sharesDianthus Therapeutics EVP, Head of R&D Simrat Randhawa reported option exercises, acquiring 23,124 common shares on Sep","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL5wp3sF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus EVP, Head of R&D Simrat Randhawa Sells USD 2.45 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","DNTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664841493","title":"Dianthus Therapeutics Grants 52,000 Inducement Stock Options at $106.62 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2664841493","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664841493?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:01","pubTimestamp":1788382890,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics grants 52,000 inducement stock options at $106.62 eachDianthus Therapeutics granted inducement stock options covering 52,000 shares to four newly hired non-executive employees on","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5qpRwy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4112","BK4139","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","BK4588","SG9999014005.SGD","IE00BQXX3D17.EUR","LU2095319765.USD","IE00B64PRP62.GBP","BK4585","IBRN","IE00BN0W2V16.EUR","LU2210150020.SGD","NDAQ","IE00B3QW5Z07.USD","SG9999014039.USD","BCDF","LU0314104364.USD","DNTH","IE00BQXX3C00.GBP","IE00BKPKM429.USD","SG9999014021.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664584117","title":"Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664584117","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664584117?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:00","pubTimestamp":1788382800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA4MXXGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","DNTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664209856","title":"Dianthus Therapeutics CEO to Join Citi Biopharma Back to School Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664209856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664209856?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:06","pubTimestamp":1788264366,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics CEO to join Citi Biopharma Back to School fireside chatDianthus Therapeutics will hold investor meetings at the Wells Fargo 21st Annual Healthcare Conference on Sept. 8, 2026.CEO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL9bJ7x6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU0310800965.SGD","LU0072461881.USD","LU0320765646.SGD","LU0980610538.SGD","SG9999014039.USD","IE00BQXX3D17.EUR","IE00BSNM7G36.USD","DNTH","LU2417539215.USD","TFNS","LU2360032135.SGD","LU1244550494.USD","IE00BQXX3F31.USD","LU1668664300.SGD","BK4112","LU1201861249.SGD","LU1144417596.USD","LU2462157665.USD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","LU1074936037.SGD","LU2125154935.USD","LU0477156953.USD","LU0128525689.USD","LU0130517989.USD","LU2210149790.SGD","BK4559","LU1506573853.SGD","LU1244550577.SGD","LU2456880835.USD","LU0052756011.USD","IYF","BK4534","LU0648001328.SGD","LU1244550221.USD","FTXO","IBRN","BK4588","LU0314104364.USD","BCDF","BK4504","LU1791807156.HKD","LU2125154778.USD","LU2236285917.USD","BK4566","SG9999014005.SGD","IE00BN0W2V16.EUR","LU1267930227.SGD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660765574","title":"Dianthus Therapeutics Director Simon Read Disposes of Common Shares Worth $326,148.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2660765574","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660765574?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:03","pubTimestamp":1787177000,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics director Simon Read disposes of common shares worth $326,148.9Dianthus Therapeutics director Simon Read exercised stock options for 2,778 common shares at USD 18.36 on Aug. 19, 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL6vl9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus Therapeutics Director Simon Read Disposes of Common Shares Worth $326,148.9","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNTH","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488079","title":"U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488079","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660488079?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:16","pubTimestamp":1786954612,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell TechnologiesAug 17 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4N44E0FK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPS","DNTH","FANG","HON","CRWD","EQT","DELL","BILT","CCAP","RDVY","CPT","AMTM","TGT","COP","CHPS","EAT","DVN","APA","ALAB","CBRE","AHR","EOG","DAVE","TDV","URAN","AEP","TINY","CLYM","ELS","CHRD","PXE","ABBV","ESS","XLE","BYND","BMRN","APP","AVB","AMLX","BCSF","DCH","DLTR","ELVN","FHLC","CVX","AVBP","AMAT","DUK","EXE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165220","title":"Dianthus Therapeutics (DNTH) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165220?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:35","pubTimestamp":1786635347,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Dianthus Therapeutics today and set a price target of $133.00. Thompson CFA co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658468579","title":"Dianthus Therapeutics SVP General Counsel Adam Veness Melepas Saham Senilai USD 2,21 Juta","url":"https://stock-news.laohu8.com/highlight/detail?id=2658468579","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658468579?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:09","pubTimestamp":1786482556,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics SVP General Counsel Adam Veness melepas saham senilai USD 2,21 jutaSVP, General Counsel dan Secretary Adam M Veness melepas seluruh kepemilikan saham biasa Dianthus Therapeutics.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4W8dyv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus Therapeutics SVP General Counsel Adam Veness Melepas Saham Senilai USD 2,21 Juta","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658966867","title":"Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658966867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658966867?lang=en_us&edition=fundamental","pubTime":"2026-08-11 10:20","pubTimestamp":1786414812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dianthus Therapeutics (DNTH), Elanco Animal Health (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dianthus-therapeutics-dnth-elanco-animal-health-elan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dianthus-therapeutics-dnth-elanco-animal-health-elan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1941712348.USD","BK4581","BK4585","BK4561","BK4588","ELAN","BK4137","LABU","LU0128526141.USD","XLV","BK4007","BK4139","LU0029874061.USD","XBI","DNTH","IBRN","HCSG","LU1941712264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939006","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658939006?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:50","pubTimestamp":1786366208,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Dianthus Therapeutic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLAM","HIYY","HEAL","BK4139","IBRN","HIMY","HMYY","BK4196","HIMS","THNR","HIMZ","DNTH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dianthustx.com","stockEarnings":[{"period":"1week","weight":-0.0662},{"period":"1month","weight":-0.2305},{"period":"3month","weight":-0.156},{"period":"6month","weight":-0.0824},{"period":"1year","weight":1.3704},{"period":"ytd","weight":0.9988}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.0313},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1417}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. It is developing DNTH103, a monoclonal antibody, which is in Phase 2 clinical trial, for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.175283},{"month":2,"riseRate":0.625,"avgChangeRate":0.224994},{"month":3,"riseRate":0.5,"avgChangeRate":0.049298},{"month":4,"riseRate":0.375,"avgChangeRate":-0.05024},{"month":5,"riseRate":0.625,"avgChangeRate":-0.041628},{"month":6,"riseRate":0.75,"avgChangeRate":0.021233},{"month":7,"riseRate":0.666667,"avgChangeRate":0.038404},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.011974},{"month":9,"riseRate":0.333333,"avgChangeRate":0.031323},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.090377},{"month":11,"riseRate":0.5,"avgChangeRate":0.042669},{"month":12,"riseRate":0.25,"avgChangeRate":-0.158671}],"exchange":"NASDAQ","name":"Dianthus Therapeutics Inc.","nameEN":"Dianthus Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Dianthus Therapeutics Inc.(DNTH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Dianthus Therapeutics Inc.(DNTH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Dianthus Therapeutics Inc.,DNTH,Dianthus Therapeutics Inc.股票,Dianthus Therapeutics Inc.股票老虎,Dianthus Therapeutics Inc.股票老虎国际,Dianthus Therapeutics Inc.行情,Dianthus Therapeutics Inc.股票行情,Dianthus Therapeutics Inc.股价,Dianthus Therapeutics Inc.股市,Dianthus Therapeutics Inc.股票价格,Dianthus Therapeutics Inc.股票交易,Dianthus Therapeutics Inc.股票购买,Dianthus Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Dianthus Therapeutics Inc.(DNTH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Dianthus Therapeutics Inc.(DNTH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}